Growth Metrics

Resmed (RMD) Total Current Liabilities (2016 - 2025)

Resmed's Total Current Liabilities history spans 16 years, with the latest figure at $1.2 billion for Q4 2025.

  • For Q4 2025, Total Current Liabilities rose 46.5% year-over-year to $1.2 billion; the TTM value through Dec 2025 reached $1.2 billion, up 46.5%, while the annual FY2025 figure was $1.0 billion, 11.91% up from the prior year.
  • Total Current Liabilities reached $1.2 billion in Q4 2025 per RMD's latest filing, down from $1.3 billion in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $1.3 billion in Q3 2025 to a low of $621.1 million in Q4 2021.
  • Average Total Current Liabilities over 5 years is $838.7 million, with a median of $771.9 million recorded in 2023.
  • Peak YoY movement for Total Current Liabilities: surged 58.93% in 2021, then dropped 24.4% in 2022.
  • A 5-year view of Total Current Liabilities shows it stood at $621.1 million in 2021, then grew by 17.98% to $732.7 million in 2022, then grew by 4.28% to $764.1 million in 2023, then rose by 11.5% to $852.0 million in 2024, then surged by 46.5% to $1.2 billion in 2025.
  • Per Business Quant, the three most recent readings for RMD's Total Current Liabilities are $1.2 billion (Q4 2025), $1.3 billion (Q3 2025), and $1.0 billion (Q2 2025).